Delivery Order SPE2DR25D3103-SPE2DR26F9V19
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,725.94 by the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Lidocaine 5% Patch 30s. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,277.57 by the Defense Logistics Agency for the supply of Lidocaine 5% Patch 30s. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed price contract with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Lidocaine 5% Patch 30s with a ceiling value of $2,305.31. The contract was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, and utilizes firm fixed price pricing. The award is unset-aside and competitively awarded, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $6,016.01. The contract is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively-awarded delivery order on October 21, 2025, by the Defense Logistics Agency to supply Lidocaine 5% Patch 30s with a ceiling value of $3,549.60. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 22, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $7,490.10 delivery order by the Defense Logistics Agency on January 6, 2026, for the supply of Lidocaine 5% Patch 30s. The contract is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 7, 2026. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,532.72 by the Defense Logistics Agency (DLA) on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract involves the supply of Lidocaine 5% Patch 30s, a topical anesthetic pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The award...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,290.87 by the Defense Logistics Agency on October 31, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The delivery order, which is competitively awarded with no set-aside designation, carries a firm fixed price and is scheduled for completion by November 3, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $7.62 thousand to supply Lidocaine 5% Patch 30s, with an ultimate completion date of January 7, 2026. The contract utilizes a firm fixed-price structure and was competitively awarded without a set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V19Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,060.28 by the Defense Logistics Agency on January 7, 2026, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location and an ultimate completion date of January 8, 2026. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and healthcare solutions provider with extensive federal contracting experience, particularly in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Defense Logistics Agency, operating under the Department of Defense, utilizes AmerisourceBergen's comprehensive IDC to source essential pharmaceutical products and medical supplies for military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The company's demonstrated capability to compete successfully on a full and open basis, combined with its substantial IDC vehicle, positions it as a critical vendor within the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/6/26 |